These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21723276)

  • 61. Regional changes in density of serotonin transporter in the brain of 5-HT1A and 5-HT1B knockout mice, and of serotonin innervation in the 5-HT1B knockout.
    Ase AR; Reader TA; Hen R; Riad M; Descarries L
    J Neurochem; 2001 Aug; 78(3):619-30. PubMed ID: 11483665
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Autonomic changes associated with enhanced anxiety in 5-HT(1A) receptor knockout mice.
    Pattij T; Groenink L; Hijzen TH; Oosting RS; Maes RA; van der Gugten J; Olivier B
    Neuropsychopharmacology; 2002 Sep; 27(3):380-90. PubMed ID: 12225695
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Corticosterone responses in 5-HT1B receptor knockout mice to stress or 5-HT1A receptor activation are normal.
    Bouwknecht JA; van der Gugten J; Hijzen TH; Maes RA; Hen R; Olivier B
    Psychopharmacology (Berl); 2001 Feb; 153(4):484-90. PubMed ID: 11243496
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Functional status of somatodendritic serotonin 1A autoreceptor after long-term treatment with fluoxetine in a mouse model of anxiety/depression based on repeated corticosterone administration.
    Rainer Q; Nguyen HT; Quesseveur G; Gardier AM; David DJ; Guiard BP
    Mol Pharmacol; 2012 Feb; 81(2):106-12. PubMed ID: 22031471
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serotonin 5-HT1A, 5-HT1B, and 5-HT2A receptor mRNA expression in subjects with major depression, bipolar disorder, and schizophrenia.
    López-Figueroa AL; Norton CS; López-Figueroa MO; Armellini-Dodel D; Burke S; Akil H; López JF; Watson SJ
    Biol Psychiatry; 2004 Feb; 55(3):225-33. PubMed ID: 14744462
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Functional consequences of 5-HT transporter gene disruption on 5-HT(1a) receptor-mediated regulation of dorsal raphe and hippocampal cell activity.
    Mannoury la Cour C; Boni C; Hanoun N; Lesch KP; Hamon M; Lanfumey L
    J Neurosci; 2001 Mar; 21(6):2178-85. PubMed ID: 11245702
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat.
    Lucas G; Du J; Romeas T; Mnie-Filali O; Haddjeri N; Piñeyro G; Debonnel G
    PLoS One; 2010 Feb; 5(2):e9253. PubMed ID: 20169084
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Knockout mice reveal opposite roles for serotonin 1A and 1B receptors in prepulse inhibition.
    Dulawa SC; Gross C; Stark KL; Hen R; Geyer MA
    Neuropsychopharmacology; 2000 Jun; 22(6):650-9. PubMed ID: 10788764
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Assessment of the serotonin reuptake blocking property of YM992: electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; De Montigny C; Blier P
    Synapse; 1999 Dec; 34(4):277-89. PubMed ID: 10529722
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. part 3.
    Herold F; Chodkowski A; Izbicki Ł; Turło J; Dawidowski M; Kleps J; Nowak G; Stachowicz K; Dybała M; Siwek A; Mazurek AP; Mazurek A; Pluciński F
    Eur J Med Chem; 2011 Jan; 46(1):142-9. PubMed ID: 21093118
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
    Guptarak J; Sarkar J; Hiegel C; Uphouse L
    Horm Behav; 2010 Jul; 58(2):290-6. PubMed ID: 20223238
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of triiodothyronine on 5-HT(1A) and 5-HT(1B) autoreceptor activity, and postsynaptic 5-HT(1A) receptor activity, in rat hypothalamus: lack of interaction with imipramine.
    Gur E; Lifschytz T; Van De Kar LD; Lerer B; Newman ME
    Psychoneuroendocrinology; 2004 Oct; 29(9):1172-83. PubMed ID: 15219641
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chronic fluvoxamine treatment changes 5-HT(2A/2C) receptor-mediated behavior in olfactory bulbectomized mice.
    Oba A; Nakagawasai O; Onogi H; Nemoto W; Yaoita F; Arai Y; Tan-No K; Tadano T
    Life Sci; 2013 Feb; 92(2):119-24. PubMed ID: 23159642
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of 5-HT receptor antagonists in mediating intracavernous pressure response induced by fluvoxamine in conscious rats.
    Aizawa N; Ishizuka O; Ogawa T; Mizusawa H; Igawa Y; Nishizawa O
    J Sex Med; 2007 Jul; 4(4 Pt 2):1108-16. PubMed ID: 17627723
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ventral hippocampal molecular pathways and impaired neurogenesis associated with 5-HT₁A and 5-HT₁B receptors disruption in mice.
    Xia L; Deloménie C; David I; Rainer Q; Marouard M; Delacroix H; David DJ; Gardier AM; Guilloux JP
    Neurosci Lett; 2012 Jul; 521(1):20-5. PubMed ID: 22622174
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Differential distribution of 5-HT 1A and 5-HT 1B-like immunoreactivities in rat central nucleus of the amygdala neurones projecting to the caudal dorsomedial medulla oblongata.
    Saha S; Gamboa-Esteves FO; Batten TF
    Brain Res; 2010 May; 1330():20-30. PubMed ID: 20226766
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT1A and 5-HT1B receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats.
    Bosker FJ; van Esseveldt KE; Klompmakers AA; Westenberg HG
    Psychopharmacology (Berl); 1995 Feb; 117(3):358-63. PubMed ID: 7770611
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats.
    Wesołowska A; Paluchowska MH; Gołembiowska K; Chojnacka-Wójcik E
    J Pharm Pharmacol; 2003 Apr; 55(4):533-43. PubMed ID: 12803776
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats.
    Yamauchi M; Tatebayashi T; Nagase K; Kojima M; Imanishi T
    Pharmacol Biochem Behav; 2004 Aug; 78(4):683-9. PubMed ID: 15301922
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of 5-HT1B receptors in the regulation of extracellular serotonin and dopamine in the dorsal striatum of mice.
    De Groote L; Olivier B; Westenberg HG
    Eur J Pharmacol; 2003 Aug; 476(1-2):71-7. PubMed ID: 12969751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.